Company / Operating Cash Flow per Share
Altimmune, Inc. Operating Cash Flow per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.93
FY2025
5-year range
-$1.91 / -$0.92
FY2021-FY2025
Trend
+13.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has increased for 3 consecutive years, from $-1.91 in FY2022 to $-0.93 in FY2025.
Based on SEC 10-K filings.
-0.93 in FY2025.
Improved from $-1.27 to $-0.93 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Altimmune, Inc.'s operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 13.0% year-over-year.
- Peak operating cash flow per share was recorded in FY2011.
- Lowest operating cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.93 | +13.0% |
| FY2024 | -$1.07 | +15.7% |
| FY2023 | -$1.27 | +33.3% |
| FY2022 | -$1.91 | -106.6% |
| FY2021 | -$0.92 | -47.3% |
| FY2020 | -$0.63 | +39.4% |
| FY2019 | -$1.03 | +96.9% |
| FY2018 | -$33.22 | -3517.0% |
| FY2017 | -$0.92 | -185.7% |
| FY2011 | -$0.32 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026